{"id":22,"date":"2012-09-10T10:14:20","date_gmt":"2012-09-10T10:14:20","guid":{"rendered":"http:\/\/www.farmacovigilanciacanarias.org\/noticias\/?p=22"},"modified":"2012-09-14T12:38:55","modified_gmt":"2012-09-14T12:38:55","slug":"nota-informativa-050712-06072012-correccion-de-la-fecha-de-publicacion-en-el-pdf","status":"publish","type":"post","link":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/2012\/09\/10\/nota-informativa-050712-06072012-correccion-de-la-fecha-de-publicacion-en-el-pdf\/","title":{"rendered":"Nota Informativa 05\/07\/12 &#8211; 06\/07\/2012: correcci\u00f3n de la fecha de publicaci\u00f3n en el pdf"},"content":{"rendered":"<p><a href=\"http:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/seguridad\/2012\/NI-MUH_FV_12-2012.htm\">Ambrisentan (<img decoding=\"async\" src=\"http:\/\/www.aemps.gob.es\/diseno\/img\/triangulo.gif\" alt=\"Tr\u00edangulo amarillo\" \/>Volibris\u00ae): contraindicaci\u00f3n en pacientes con fibrosis pulmonar idiop\u00e1tica<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ambrisentan (Volibris\u00ae): contraindicaci\u00f3n en pacientes con fibrosis pulmonar idiop\u00e1tica<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-22","post","type-post","status-publish","format-standard","hentry","category-seguridad"],"_links":{"self":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/22","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/comments?post=22"}],"version-history":[{"count":2,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/22\/revisions"}],"predecessor-version":[{"id":53,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/22\/revisions\/53"}],"wp:attachment":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/media?parent=22"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/categories?post=22"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/tags?post=22"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}